Key result
A 12-week home-based cardio-oncology telerehabilitation program significantly increased cardiorespiratory fitness by 2.6 ml/kg/min in hematological cancer survivors.
Why the study?
Cardiovascular disease is a competing mortality cause in hematological cancer survivors, but accessibility to cardio-oncology rehabilitation was poor during the COVID-19 pandemic.
Does a 12-week home-based cardio-oncology telerehabilitation program improve cardiorespiratory fitness in hematological cancer survivors?
Comparison
12-week home-based cardio-oncology rehabilitation using a telerehabilitation approach
Design
Prospective single-arm interventional study
Follow-up
12 weeks
Authors
Loading...
May support home-based telerehabilitation in hematological cancer survivors; hypothesis-generating pending randomized confirmation.
Does a 12-week home-based cardio-oncology telerehabilitation program improve cardiorespiratory fitness in hematological cancer survivors?
Mean Difference: 2.6 (95% CI -4.32–9.52)
Absolute Event Rate: 23.2% vs 20.6%
p-value: p=<0.05
A 12-week home-based cardio-oncology telerehabilitation program is feasible, safe, and significantly improves cardiorespiratory fitness in hematological cancer survivors.
Filáková et al. (2023) studied Hematological cancer (Lymphoma) (n=11). Home-based cardio-oncology rehabilitation (CORE) using a telerehabilitation platform vs. Baseline (single-arm study) was evaluated on Cardiorespiratory fitness (peak oxygen uptake, pVO2) (MD 2.6 ml/kg/min, 95% CI -4.32 to 9.52, p=<0.05). A 12-week home-based cardio-oncology telerehabilitation program significantly increased cardiorespiratory fitness by 2.6 ml/kg/min in hematological cancer survivors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: